Effects of simvastatin, an HMG‐CoA reductase inhibitor, in patients with hypertriglyceridemia

Background: Patients with elevated levels of serum triglyc‐erides (TG) often have other associated lipid abnormalities (e.g., low levels of high‐density lipoprotein cholesterol [HDL‐C]) and are at increased risk of developing coronary heart disease. Although the therapeutic benefits of 3‐hydroxy‐3‐m...

詳細記述

保存先:
書誌詳細
出版年:Clin Cardiol
主要な著者: Isaacsohn, Jonathan, Hunninghake, Donald, Schrott, Helmut, Dujovne, Carlos A., Knopp, Robert, Weiss, Stuart R., Bays, Harold, Crousei, John R., Davidson, Michael H., Keilson, Leonardm, McKenney, James, Korenman, Stanleyg, Dobs, Adrians, Stein, Evan, Krauss, Ronald M., MacCubbin, Darbie, Cho, Meeh Yung, Plotkin, Diane J., Mitchel, YALE B.
フォーマット: Artigo
言語:Inglês
出版事項: Wiley Periodicals, Inc. 2006
主題:
Clinical Investigations
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6654219/
https://ncbi.nlm.nih.gov/pubmed/12539808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960260105
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料